Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




MR Prostate Coil Customizes Treatment Planning

By HospiMedica staff writers
Posted on 17 Aug 2006
A new prostate coil is designed to produce very accurate magnetic resonance (MR) images for targeted prostate cancer treatment.

To enable personalized treatment planning that may reduce considerable side effects of prostate cancer treatment, Medrad (Indianola, PA, USA) and GE Healthcare (Chalfont St. More...
Giles, UK) announce the availability of the first endorectal coil for 3.0T MR prostate imaging. The Medrad 3.0T Prostate eCoil is available for GE Signa HDx 3.0T MR scanners.

Patients diagnosed with prostate cancer frequently undergo either a radical prostatectomy, or radiation treatment over large portions of the prostate to combat the cancer. The after-effects on the patient can include impotence, urinary incontinence, and bleeding. Medrad created the 3.0T Prostate eCoil to produce very accurate diagnostic images of the prostate that may enable early diagnosis and staging of prostate cancer. The coil can also be used to plan radiation therapy in a way that helps clinicians localize treatment to only the affected part of the gland. By giving clinicians more accurate images for use in planning and delivering targeted treatment, the eCoil may help them customize the patient's treatment.

The eCoil balloon conforms to the size and shape of the prostate for consistent contact between the gland and the signal-amplifying elements of the coil. The result is small field-of-view (FOV) and high spatial resolution, sensitivity, and specificity that provide clearer images of the prostate.

John Kurhanewicz, Ph.D., director of the Prostate Imaging Group and Biomedical NMR Lab and professor of radiology and pharmaceutical chemistry at the University of California, San Francisco (UCSF; USA) School of Medicine, has noted similar results on a GE scanner. "The increased spectral dispersion obtainable at 3.0T allows for better quantification of metabolites, notably the elevation of choline resonance, which has emerged as the most specific marker for prostate cancer,” said Dr. Kurhanewicz.

The Prostate eCoil is also available for 1.5T magnet strength environments and is one of Medrad's Leading Image MR Coil products.



Related Links:
Medrad
GE Healthcare

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Gold Member
Electrode Solution and Skin Prep
Signaspray
X-Ray System
Leonardo DR mini III
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.